Early research (Phase 1)Study completedNCT00270465
What this trial is testing
Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients
Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 17